Format

Send to:

Choose Destination
See comment in PubMed Commons below
Rontgenpraxis. 2007;56(4):137-44.

[Radiotherapy of Graves' ophthalmopathy--state of the art and review of the literature].

[Article in German]

Author information

  • 1Klinik und Poliklinik für Strahlentherapie, Klinikum der Universität zu Köln, Joseph-Stelzmann-Str. 9, 50924 Köln, Germany. Hans-Theodor.Eich@medizin.uni-Koeln.de

Abstract

Graves' ophthalmopathy (GO), the most frequent extrathyroidal manifestation of Graves' disease, is a disorder of autoimmune origin, the pathogenic mechanisms of which are still incompletely understood. Although GO is severe in only 3-5% of affected individuals, quality of life is severely impaired even in patients with mild GO. The role of radiotherapy in the management of GO is discussed controversially. However, recent randomized clinical trials have, with one exception, confirmed that orbital radiotherapy is an effective and safe therapeutic procedure for GO. This article describes the sequences, dosages and fractionation schemes as well as the risks and side effects of the radiotherapy.

PMID:
17390953
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk